Jiří Lukáš
Impact in
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 29
- Cancer-related Molecular Pathways 27
-
- Cancer Research and Treatments 4
- Co-authors
- Jiří BártekJiřina BártkováMichele PaganoGiulio DraettaVéronique BaldinMaría Jesús MarcoteM. StraußZ Stasková
In The Last Decade
Jiří Lukáš
52 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 3.7k
- Cancer Research 899
- Biotechnology 504
- Molecular Biology 4.0k
- Cell Biology 928
Countries citing papers authored by Jiří Lukáš
This map shows the geographic impact of Jiří Lukáš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Lukáš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Lukáš more than expected).
Fields of papers citing papers by Jiří Lukáš
This network shows the impact of papers produced by Jiří Lukáš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Lukáš. The network helps show where Jiří Lukáš may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiří Lukáš, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2014 | 4 | |
| 3 | 2011 | 58 | |
| 4 | 2010 | 19 | |
| 5 | 2010 | 15 | |
| 6 | 2010 | 138 | |
| 7 | 2008 | 17 | |
| 8 | 2007 | 92 | |
| 9 | 2007 | 412 | |
| 10 | 2007 | 100 | |
| 11 | 1997 | 9 | |
| 12 | WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary and endometrium | 1996 | 30 |
| 13 | The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. | 1996 | 239 |
| 14 | 1996 | 4 | |
| 15 | Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. | 1995 | 203 |
| 16 | Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control. | 1995 | 5 |
| 17 | 1993 | 83 | |
| 18 | 1993 | 278 | |
| 19 | 1992 | 8 | |
| 20 | 1992 | 88 |
About Jiří Lukáš
Jiří Lukáš is a scholar working on Oncology, Biotechnology, Molecular Biology, Genetics and Cell Biology, having authored 53 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), DNA Repair Mechanisms (11 papers), Virus-based gene therapy research (4 papers), Cancer Research and Treatments (4 papers), RNA modifications and cancer (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Microtubule and mitosis dynamics (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Oncology (3.7k citations), Cancer Research (899 citations), Biotechnology (504 citations), Molecular Biology (4.0k citations) and Cell Biology (928 citations). Jiří Lukáš has collaborated with scholars based in Denmark, Czechia and Germany. Frequent co-authors include Jiří Bártek, Jiřina Bártková, Michele Pagano, Giulio Draetta, Véronique Baldin, María Jesús Marcote, M. Strauß, Z Stasková, Heiko Müller and Mike Strauss. Their work appears in journals such as Oncogene, The Journal of Cell Biology, International Journal of Andrology, Cell Death and Differentiation and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.